These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1332811)

  • 1. [Effects of spleen on inducing portal hypertension and liver cirrhosis in rats].
    Chen S
    Zhonghua Yi Xue Za Zhi; 1992 Jun; 72(6):338-40, 381-2. PubMed ID: 1332811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of splenectomy on CCl4-induced liver fibrosis in rats.
    Chen D; Liu W; Leng E; Wu B
    Chin Med J (Engl); 1998 Sep; 111(9):779-83. PubMed ID: 11155665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced liver cirrhosis.
    Mizumoto M; Arii S; Furutani M; Nakamura T; Ishigami S; Monden K; Ishiguro S; Fujita S; Imamura M
    J Surg Res; 1997 Jul; 70(2):124-33. PubMed ID: 9245560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
    Laviña B; Gracia-Sancho J; Rodríguez-Vilarrupla A; Chu Y; Heistad DD; Bosch J; García-Pagán JC
    Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial splenectomy, transposition of the spleen to the abdominal wall or splenohepatoplasty in portal hypertensive rats. Effects on portal venous pressure and homeostasis--microscopical appearance of the transposed spleen.
    Tröbs RB; Bennek J
    Eur J Pediatr Surg; 1998 Jun; 8(3):155-62. PubMed ID: 9676398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The mechanism for splenic promoting effects on liver cirrhosis].
    Wang Q; Xia S; Jiang H
    Zhonghua Yi Xue Za Zhi; 1995 Oct; 75(10):594-8, 638. PubMed ID: 8697073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
    Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
    Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An experimental model of liver damage and portal hypertension induced by a single dose of monocrotaline.
    Perazzo J; Eizayaga F; Romay S; Bengochea L; Pavese A; Lemberg A
    Hepatogastroenterology; 1999; 46(25):432-5. PubMed ID: 10228836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of Ginkgo biloba extract on portal hypertension and hepatic microcirculation in rats].
    Zhang CQ; Zhu YH; Wang J; Liang B; Xu HW; Qin CY
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):245-8. PubMed ID: 17456308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early propranolol administration does not prevent development of esophageal varices in cirrhotic rats.
    Alatsakis M; Ballas KD; Pavlidis TE; Psarras K; Rafailidis S; Tzioufa-Asimakopoulou V; Marakis GN; Sakantamis AK
    Eur Surg Res; 2009; 42(1):11-6. PubMed ID: 18971580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Curative effect of interferon-alpha on rat liver fibrosis induced by CCl4].
    Yang HX; Yi YR
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 33(10):919-25. PubMed ID: 19001734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenobarbital in comparison with carbon tetrachloride and phenobarbital-induced cirrhosis in rat liver regeneration.
    Hashimoto M; Kothary PC; Raper SE
    J Surg Res; 1999 Feb; 81(2):164-9. PubMed ID: 9927535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Akt gene therapy for cirrhotic rats with portal hypertension].
    Huang FZ; Deng G; Liu XY; Luo CQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):31-7. PubMed ID: 18245901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron overload facilitates hepatic fibrosis in the rat alcohol/low-dose carbon tetrachloride model.
    Mackinnon M; Clayton C; Plummer J; Ahern M; Cmielewski P; Ilsley A; Hall P
    Hepatology; 1995 Apr; 21(4):1083-8. PubMed ID: 7705783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhein inhibits liver fibrosis induced by carbon tetrachloride in rats.
    Guo MZ; Li XS; Xu HR; Mei ZC; Shen W; Ye XF
    Acta Pharmacol Sin; 2002 Aug; 23(8):739-44. PubMed ID: 12147197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relation of hepatic pathologic changes and portal venous pressure in the course of cirrhosis in rats].
    Wu ZY
    Zhonghua Wai Ke Za Zhi; 1990 Mar; 28(3):147-50, 189. PubMed ID: 2379424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: a new target to treat portal hypertension?
    Sansoè G; Aragno M; Mastrocola R; Restivo F; Mengozzi G; Smedile A; Rosina F; Danni O; Parola M; Rizzetto M
    J Hepatol; 2005 Nov; 43(5):791-8. PubMed ID: 16085334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of hepatic arterial flow on portal venous and hepatic venous wedged pressure in the isolated perfused CCl4-cirrhotic liver.
    Zipprich A; Loureiro-Silva MR; D'Silva I; Groszmann RJ
    Am J Physiol Gastrointest Liver Physiol; 2008 Jul; 295(1):G197-G202. PubMed ID: 18497333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive hepatocytic fatty infiltration in rats with prehepatic portal hypertension.
    Alonso MJ; Aller MA; Corcuera MT; Nava MP; Gömez F; Angulo A; Arias J
    Hepatogastroenterology; 2005; 52(62):541-6. PubMed ID: 15816474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of spleen on immune function of rats with liver cancer complicated by liver cirrhosis.
    Yao YM; Liu QG; Yang W; Zhang M; Ma QY; Pan CE
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):242-6. PubMed ID: 14599977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.